SEC Form 4 · accession 0001144204-18-050781
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sunil Bhonsle
Officer — See Remarks · Director
Period of report
Sep 21, 2018
Accepted (ET)
Sep 25, 2018 · 7:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 21, 2018 | P | 300,000 | $0.25 | A | 435,578 | D | |
| Common StockF1 | holding | — | — | — | 54,684 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.25 | Sep 21, 2018 | A | 300,000 | A | Sep 25, 2023 | Sep 25, 2023 | common stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The reporting person serves as trustee of the family trust.
Remarks
Executive Vice President and Chief Operating Officer